Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Intensity Therapeutics Inc (NASDAQ: INTS) closed the day trading at $0.57 up 6.54% from the previous closing price of $0.54. In other words, the price has increased by $6.54 from its previous closing price. On the day, 14.51 million shares were traded. INTS stock price reached its highest trading level at $0.625 during the session, while it also had its lowest trading level at $0.5245.
Ratios:
For a better understanding of INTS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INTS now has a Market Capitalization of 34199408 and an Enterprise Value of 24731904.
Stock Price History:
The Beta on a monthly basis for INTS is 4.21, which has changed by -0.8338509 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, INTS has reached a high of $3.40, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is 81.96%, while the 200-Day Moving Average is calculated to be -38.34%.
Shares Statistics:
Over the past 3-months, INTS traded about 29.76M shares per day on average, while over the past 10 days, INTS traded about 168547020 shares per day. A total of 49.06M shares are outstanding, with a floating share count of 43.80M. Insiders hold about 10.72% of the company’s shares, while institutions hold 4.12% stake in the company. Shares short for INTS as of 1760486400 were 2253998 with a Short Ratio of 0.08, compared to 1757894400 on 254272. Therefore, it implies a Short% of Shares Outstanding of 2253998 and a Short% of Float of 4.8.
Earnings Estimates
Investors are keenly observing as 2 analysts analyze and rate. The current performance of Intensity Therapeutics Inc (INTS) in the stock market.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.35 and -$0.38 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is -$0.37, with 2.0 analysts recommending between -$0.24 and -$0.5.
